Study About Contrast Media
Multicentre Randomized Trial on the Timing and Effect of Contrast Media on Patients with Adhesive Small Bowel Obstruction
1 other identifier
interventional
120
1 country
1
Brief Summary
Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2022
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMarch 30, 2025
December 1, 2024
1.6 years
December 4, 2022
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
SBO resolution
SBO resolution with conservative measures * passing gas * bowel movement * CM in the colon on the X-ray
Period of hospitalization- approximately 5 days
Study Arms (2)
Contrast media 4 hours
ACTIVE COMPARATORPatients will receive contrast media after 4 hours of nasogastric decompression
Contrast media 24 hours
ACTIVE COMPARATORPatients will receive contrast media after 24 hours of nasogastric decompression
Interventions
CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered
Eligibility Criteria
You may qualify if:
- Patients 18 years or older
- Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation
- No peritonitis present, no need for an emergent surgery
- Patients sign an informed consent
You may not qualify if:
- Patients younger than 18 yeas
- Patients with mechanical small bowel obstruction caused by incarcerated hernias
- Patients with mechanical small bowel obstruction caused by carcinomatosis
- Patients with paralytic small bowel obstruction
- Patients who have undergone surgery within 6 weeks
- Patients who do not want to be enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Tartulead
- North Estonia Medical Centrecollaborator
Study Sites (1)
Tartu University Hospital
Tartu, Tartu, 50406, Estonia
Study Officials
- PRINCIPAL INVESTIGATOR
Liis Jaanimäe
University of Tartu
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Sealed envelope randomisation
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General Surgeon, PhD student
Study Record Dates
First Submitted
December 4, 2022
First Posted
January 10, 2023
Study Start
September 1, 2023
Primary Completion
March 30, 2025
Study Completion
August 1, 2025
Last Updated
March 30, 2025
Record last verified: 2024-12